Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway

Therapeutic response to selective serotonin (5-HT) reuptake inhibitors in Major Depressive Disorder (MDD) varies considerably among patients, and the onset of antidepressant therapeutic action is delayed until after 2 to 4 weeks of treatment. The objective of this study was to analyze changes within...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Zhu, Hongjie, Bogdanov, Mikhail B., Boyle, Stephen H., Matson, Wayne, Sharma, Swati, Matson, Samantha, Churchill, Erik, Fiehn, Oliver, Rush, John A., Krishnan, Ranga R., Pickering, Eve, Delnomdedieu, Marielle, Kaddurah-Daouk, Rima, Network, Pharmacometabolomics Research
التنسيق: Artigo
اللغة:Inglês
منشور في: Public Library of Science 2013
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3714282/
https://ncbi.nlm.nih.gov/pubmed/23874572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0068283
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة